Officials at UW-Madison’s School of Medicine are nearing acceptance into a late-stage clinical trial that would allow them to test a promising new drug for stroke victims.
Office of Strategic Communication
Officials at UW-Madison’s School of Medicine are nearing acceptance into a late-stage clinical trial that would allow them to test a promising new drug for stroke victims.